ITEMS IN AFP WITH KEYWORD:
Prostate cancer is the second most common cancer in men, with a lifetime prevalence of 17 percent. Prostate cancer symptoms generally occur in advanced stages, making early detection desirable. Digital rectal examination and prostate-specific antigen testing are the most commonly used screening tool...
There is insufficient evidence to determine whether screening for prostate cancer reduces mortality or impacts quality of life.
Dec 15, 2005 Issue
Predicting the Risk of Recurrence After Surgery for Prostate Cancer [Point-of-Care Guides]
A previous Point-of-Care Guide identified a clinical decision rule that estimates the likelihood of an abnormal biopsy for prostate cancer. One of the next questions facing the patient and his physician is the likelihood of recurrence after surgery.
Considerable uncertainty surrounds the screening, diagnosis, and management of prostate cancer.
Controversy surrounds the management options for localized prostate cancer-conservative management, prostatectomy, and radiation. Choosing among these options is difficult because of long-term side effects that include sexual, urinary, and bowel dysfunction. Some recent studies suggest that patients...
Case study: DS, a 55-year-old African-American man, comes into your office for a physical examination. While talking about his family history, you learn that his father had prostate cancer. DS asks if he should be tested for prostate cancer.
This is the current U.S. Preventive Services Task Force (USPSTF) recommendation on screening for prostate cancer and the supporting scientific evidence.
Neurologic complications continue to pose problems in patients with metastatic prostate cancer. From 15 to 30 percent of metastases are the result of prostate cancer cells traveling through Batson's plexus to the lumbar spine. Metastatic disease in the lumbar area can cause spinal cord compression. ...
The American Urological Association (AUA) has released a policy report on the use of prostate-specific antigen (PSA) in screening for and monitoring of prostate cancer.
The American Cancer Society and other national medical organizations emphasize the need for routine screening for prostate cancer in men over the age of 50. The serum prostate-specific antigen (PSA) assay is the test most commonly recommended for the purpose of screening. However, when PSA screening...